Psoriasis (PsO) Clinical Trials

14 recruiting

Psoriasis (PsO) Trials at a Glance

14 actively recruiting trials for psoriasis (pso) are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Alexandria, Amman, and Amsterdam. Lead sponsors running psoriasis (pso) studies include Charite University, Berlin, Germany, Bristol-Myers Squibb, and Alexandria University.

Browse psoriasis (pso) trials by phase

Treatments under study

About Psoriasis (PsO) Clinical Trials

Looking for clinical trials for Psoriasis (PsO)? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Psoriasis (PsO) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Psoriasis (PsO) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 4

Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis

Psoriasis (PsO)
Hospital Universitario Dr. Jose E. Gonzalez62 enrolled1 locationNCT07401992
Recruiting

Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada

Psoriasis (PsO)Moderate to Severe Psoriasis
Chronicle Academy80 enrolled6 locationsNCT07370766
Recruiting
Phase 1

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Psoriasis (PsO)Atopic Dermatitis (AD)
LAPIX Therapeutics Inc.48 enrolled3 locationsNCT06982352
Recruiting

Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis

Psoriatic Arthritis (PsA)Psoriasis (PsO)
Charite University, Berlin, Germany500 enrolled1 locationNCT07298265
Recruiting
Phase 2

A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults

Psoriasis (PsO)
Ahmed Ibrahim36 enrolled1 locationNCT07233291
Recruiting
Phase 2

A Phase 2 Study of HB0017 in Psoriasis Patients

Psoriasis (PsO)
Huabo Biopharm Co., Ltd.200 enrolled18 locationsNCT06592274
Recruiting
Early Phase 1

Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study

Psoriasis (PsO)
Alexandria University24 enrolled1 locationNCT07169019
Recruiting

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

Atopic DermatitisPsoriasis (PsO)Vitiligo Vulgaris+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS400 enrolled1 locationNCT06801821
Recruiting

Molecular Inflammation Board at the Center for Personalized Medicine

Psoriasis (PsO)Psoriasis ArthritisInflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)+1 more
University Hospital Tuebingen3,000 enrolled1 locationNCT07132333
Recruiting

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Chronic Spontaneous Urticaria (CSU)Hidradenitis Suppurativa (HS)Psoriasis (PsO)+2 more
Leiden University Medical Center840 enrolled8 locationsNCT07021495
Recruiting

A Study to Assess Deucravacitinib Safety in Pregnancy

Psoriasis (PsO)
Bristol-Myers Squibb900 enrolled1 locationNCT07017699
Recruiting

A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)

Psoriasis (PsO)Psoriasis ArthritisSecukinumab+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School50 enrolled2 locationsNCT06987292
Recruiting
Phase 3

Effect of Semaglutide in Patients With Psoriasis and Obesity

Obesity and OverweightPsoriasis (PsO)
The University of Hong Kong14 enrolled1 locationNCT06937060
Recruiting
Not Applicable

Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)

Psoriasis (PsO)Psoriasis Arthritis
Charite University, Berlin, Germany30 enrolled1 locationNCT06905028